Reportstack has announced a new market research report on the Global Needle-free Drug Delivery Technologies Market 2015-2019. The introduction and enforcement of various laws mandating the use of safety needles/syringes and needle-free devices is one of the major trends in this market. With the introduction and enforcement of such laws, the Healthcare and Pharmaceuticals markets worldwide are now switching to the mandatory use of safety needles/syringes and needle-free devices to help protect those at risk of infection from NSIs and other unsafe injection practices. The Global Needle-free Drug Delivery Technologies market is expected to grow at a CAGR of 13.50 percent during the period 2014-2019.
With painless drug delivery and ease of use, needle-free systems have been successful in addressing a range of challenges, such as patient compliance and acceptability, particularly in self-administration settings faced by traditional needle drug delivery methods. Needle-free injections overcome the patient's disinclination toward needles and thereby reduce the risk of NSIs.
“Nowadays, patients are progressively opting for devices that help them diagnose and treat diseases in their own homes,”.
“An increase in the geriatric population has shifted the focus of patients toward home healthcare devices, such as glucose monitoring devices, nebulizers, inhalers, and others.”
To define the market conditions in the next 3-4 years, the analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
Complete report available @ Global Needle-free Drug Delivery Technologies market 2015-2019.